FAQ

  1. What type of work are you involved in the cancer therapy research?
    30/04/2014

    The cancer research program at JRC-ITU focuses on all stages of developing targeted alpha therapy (TAT) from bench to bedside, including the development of innovative methods for the production of alpha emitters, pre-clinical studies in vitro and in vivo, as well as conducting clinical trials in collaboration with hospitals in Europe and world-wide.

    Institutes: ITU
    Keywords: nuclear, actinide, cancer, citizen, collaboration, health, innovation, microbiology
  2. Is the Karlsruhe nuclide chart available on-line?
    30/04/2014

    Yes, since January 2012 the management of the nuclide chart has been licensed to Nucleonica GmbH – this company provides many online tools for analysing and interacting with the nuclide chart online.

    Institutes: ITU
    Keywords: nuclear, fuel, actinide, reference data, R&D
  3. What is the JRC?
    30/04/2014

    The European Commission's Joint Research Centre (JRC) is a department (Directorate-General, DG) of the European Commission providing independent scientific and technological support for EU policy-making. It works closely on the development of EU legislation with the relevant Commission services, such as the Agricultural, Enterprise, Environment, and Health and Consumer Protection DGs. Knowledge comes from specific application- and issue-oriented research within the seven JRC Institutes and close co-operation with over 1000 public and private organisations in 150 networks in Member State and applicant countries. The JRC also liases with non-EU and global scientific and standard-setting bodies.

    Institutes: IES, IHCP
    Keywords: actinide